Brief: Bergenbio Announces Safety Data From Dose Escalation Phase 1B In First Line NSCLC Patients

Oncoinvent ASA

07/10/2024 06:38

Oct 7 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * ANNOUNCES SAFETY DATA FROM DOSE ESCALATION PHASE 1B IN
FIRST
LINE NSCLC PATIENTS
    * TRIPLET COMBINATION WELL TOLERATED WITH NO NEW SAFETY
SIGNALS

Source text for Eikon:  ID:nPremVDKxa 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))